National Foundation for Cancer Research (NFCR) shared a post on LinkedIn:
“Over 80 cancer drugs. One accidental discovery.
Dr. Tony Hunter wasn’t looking to change medicine when his lab stumbled onto a finding that would reshape oncology. But that’s exactly what happened — and decades later, the ripple effects are still being felt in clinics around the world.
In the upcoming episode of All Things Cancer, NFCR President and CEO Dr. Sujuan Ba sits down with Dr. Hunter to discuss the science that started it all, the role of AI in accelerating cancer research, the growing concern around research funding, and what gives him hope about the road ahead.
Episode dropping soon. Follow All Things Cancer so you’re first to hear it.”
More posts about NFCR.